AI

Both RetiKid and RetiAge use AI deep learning algorithms to screen for health conditions in retinal images.

This follows last year's FDA approvals in the US.

Also: Oma Fertility emerges from stealth with $37.5 million in equity and debt financing, and payer data platform Abacus Insights scores $28 million.

The round comes nearly a year after the company announced a $66 million Series C.

The study found a machine learning model detected traumatic intracranial hemorrhage with a sensitivity of 74% and a specificity of 75% using information collected before patients were transported to the hospital.

The company is also close to getting its patent for the Us2.v1 software recognised in the US.

They will provide the first access to an AI-enabled minimal residual disease test in India.

Also: Drug discovery platform Insilico Medicine raises $60 million, Women's virtual care startup Visana Health brings in $2.6 million and digital reproductive care clinic Choix scoops up $1 million.

Two variants of the Annalise CXR Edge products will be offered in Australia.

The AI solution has been trained based on a data set of 3.2 billion patient visits.